Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE (ttm):
Div Rate:
Yield:
Market Cap:
Volume:
FOCUS
|
|
TRANSCRIPTS
|
OTHER NEWS & PR
PRO Articles
There is research on this stock available only to PRO subscribers.
Other Articles
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Novo Nordisk: Encouraging Pipeline NewsZacks Investment Research • Oct. 23, 2012 -
-
-
-
-
Novo Nordisk A/S Discusses Q3 2013 Results (Webcast)Oct. 31, 2013
-
Novo Nordisk A/S - Special CallFeb. 11, 2013
-
at MarketWatch.com (Feb 26, 2014)
-
at MarketWatch.com (Feb 25, 2014)
-
at MarketWatch.com (Dec 27, 2013)
-
at Fox Business (Nov 14, 2013)
-
at MarketWatch.com (Oct 31, 2013)
-
at MarketWatch.com (Sep 16, 2013)
-
at CNBC.com (Jun 28, 2013)
-
at CNBC.com (Jun 24, 2013)
-
at MarketWatch.com (Mar 18, 2013)
-
at MarketWatch.com (Mar 4, 2013)
-
at MarketWatch.com (Feb 11, 2013)
-
at MarketWatch.com (Feb 11, 2013)
-
at Fox Business (Feb 11, 2013)
-
at MarketWatch.com (Jan 11, 2013)
-
at MarketWatch.com (Dec 7, 2012)
-
at MarketWatch.com (Nov 27, 2012)
-
at MarketWatch.com (Nov 9, 2012)
-
at CNBC.com (Nov 9, 2012)
-
at MarketWatch.com (Nov 6, 2012)
-
at MarketWatch.com (Nov 6, 2012)
OTHER NEWS
-
at MarketWatch.com (Feb 26, 2014)
-
at MarketWatch.com (Feb 25, 2014)
-
at MarketWatch.com (Dec 27, 2013)
-
at Fox Business (Nov 14, 2013)
-
at MarketWatch.com (Oct 31, 2013)
NVO vs. ETF Alternatives
Company Description
Novo-Nordisk A/S is a healthcare company that is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company has two business segments: diabetes care and biopharmaceuticals.
